![]() |
市場調查報告書
商品編碼
1380263
2023-2030年全球光療設備市場Global Phototherapy Equipment Market 2023-2030 |
全球光療設備市場按產品、應用和最終用戶細分。根據產品,市場分為傳統光療設備、LED光療設備和光纖光療設備。根據應用,市場細分為皮膚病治療和新生兒黃疸管理。此外,根據最終用戶,市場分為醫院、診所和家庭護理。其中,LED光療設備細分市場預計將佔據相當大的市場佔有率。基於 LED 的光療用於治療細紋、牛皮癬和痤瘡等皮膚病。患有此類皮膚病的人數的增加預計將增加對 LED 光療設備的需求。痤瘡是人們最常見的皮膚病。據估計,11 至 30 歲的人中 80% 至少患有輕度痤瘡,使其成為全球第八大流行疾病。
其中,皮膚病治療細分領域預計將在全球光療設備市場中佔據相當大的佔有率。光療是治療多種皮膚病的高效療法。光療使用特定波長的光來減少發炎、減緩皮膚細胞增殖並促進癒合。光療是一種非侵入性治療選擇,不需要外科手術或服用藥物。這對於喜歡非藥物治療或不能服用某些藥物的人來說是一個不錯的選擇。光療還可以透過抑制過度活躍的免疫反應來減少與牛皮癬相關的發紅、腫脹和搔癢。
美國、中國和印度等國家皮膚病的增加導致光療設備的使用量增加。據國家銀屑病基金會稱,銀屑病影響著美國超過 800 萬人和全球 1.25 億人。遺傳至關重要,因為如果父母之一患有牛皮癬,那麼孩子患牛皮癬的幾率約為 28%。如果父母雙方都患有牛皮癬,孩子患牛皮癬的幾率約為 65%。在白斑症和斑禿等自體免疫皮膚病中,免疫系統會錯誤地攻擊健康細胞,導致色素脫失或掉髮。光療可以幫助改變免疫反應,降低身體對組織的攻擊。
全球光療設備市場根據地理位置進一步細分,包括北美(美國和加拿大)、歐洲(英國、義大利、西班牙、德國、法國和歐洲其他地區)、亞太地區(印度、中國、日本) 、韓國和亞洲其他地區)以及世界其他地區(中東和非洲以及拉丁美洲)。其中,由於北美地區的成長,預計北美將在全球市場中佔據顯著佔有率。新生兒黃疸和皮膚病的發生以及人們對使用新技術的認知不斷提高。
在所有地區中,由於醫院和專科診所建設不斷增加以提供有效的醫療保健解決方案,預計亞太地區在預測期內將以相當大的CAGR成長。除此之外,大眾醫療保健支出的增加也促進了市場的成長。 2019年,中國醫療保健進出口額雙雙成長,達到2011年以來的最高水準。歐洲、亞洲、北美是中國醫療保健對外貿易的三大大陸合作夥伴。影響中國該產業的主要因素和促進因素,特別是中國政府在發布關鍵發展計畫和法規方面日益發揮的支持作用,以及中國人口的快速老化。中國醫藥產業一直在穩步擴張,預計到2023年底將達到1,618億美元,約佔全球市場的30%。但由於中國頭部製藥企業和跨國跨國製藥公司(包括美國製藥公司)佔了大部分市場銷售,美國中小企業製藥公司的開拓機會受到限制。
服務光療設備市場的主要公司包括: Daavlin Company、Aeroflow, Inc.、Philips Lighting Holding BV、Signify Holding、Atom Medical Corporation、Herbert Waldmann GmbH & Co. KG、Hill-Rom Holdings, Inc. 等。市場參與者透過各種策略(包括併購、合作、合作、融資和新產品發布),為市場成長做出了巨大貢獻,以保持市場競爭力。例如,2022 年 4 月,飛利浦與芬蘭奧盧大學醫院簽署了長期策略合作夥伴關係,提供先進的影像導引專科護理。它們都將配備飛利浦影像導引治療系統 Azurion 和先進的影像引導治療平台 FlexArm,提供最新的創新技術,幫助醫生提高效率、工作流程和治療結果。
Title: Global Phototherapy Equipment Market Size, Share & Trends Analysis Report by Product (Conventional Phototherapy Equipment, LED Phototherapy Equipment, and Fiber Optic Phototherapy Equipment), by Application (Skin Disease Treatment and Neonatal Jaundice Management), and by End-user (Hospitals, Clinics and Homecare),Forecast Period (2023-2030).
Global phototherapy equipment market is anticipated to grow at a CAGR of 5.2% during the Forecast Period (2023-2030). owing to increase in the prevalence of skin diseases, rise in incidence of neonatal jaundice, continuous technological advancements in the area of phototherapy, and adoption of LED-based phototherapy equipment. Phototherapy equipment is used for the treatment of various skin-related diseases such as mycosis fungoides, psoriasis, morphea, vitiligo, and others.
The global phototherapy equipment market is segmented by product, application, and end-user. Based on the product, the market is sub-segmented into conventional phototherapy equipment, led phototherapy equipment, and fiber optic phototherapy equipment. Based on the application, the market is sub-segmented into skin disease treatment and neonatal jaundice management. Further, based on end-users, the market is sub-segmented into hospitals, clinics, and home care. Among the products, the LED phototherapy equipment sub-segment is anticipated to hold a considerable share of the market. LED-based phototherapy is used to treat skin diseases such as fine lines, psoriasis, and acne. The rise in the number of people suffering from such skin conditions is expected to boost the demand for LED-based phototherapy devices. Acne is the most common skin condition that people experience. An estimated 80% of people ages 11 to 30 will have at least a mild form of acne making it the eighth most prevalent disease worldwide.
Among the applications, the skin disease treatment sub-segment is expected to hold a considerable share of the global phototherapy equipment market. Phototherapy is a highly effective therapy for a variety of skin diseases. Phototherapy uses specific wavelengths of light to reduce inflammation, slow skin cell proliferation, and improve healing. Phototherapy is a non-invasive treatment option that does not require surgical procedures or the administration of drugs. This makes it a good choice for people who prefer non-pharmacological treatments or who cannot take certain medications. Phototherapy also reduces the redness, swelling, and itching associated with psoriasis by suppressing the hyperactive immune response.
Increasing skin diseases in countries such as the US, China, and India have accounted for the rise in the use of phototherapy equipment. According to the National Psoriasis Foundation, Psoriatic disease impacts more than 8 million people in the US and 125 million people globally. Genetics are crucial because if one parent has psoriasis, a child has about a 28% chance of developing psoriasis. If both parents have psoriasis, a child has approximately a 65% chance of developing psoriasis. The immune system mistakenly assaults healthy cells in autoimmune skin illnesses such as vitiligo and alopecia areata, resulting in depigmentation or hair loss. Phototherapy can help modify the immune response, lowering the body's attack on tissues.
The global phototherapy equipment market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, North America is anticipated to hold a prominent share of the market across the globe, owing to the rising occurrence of neonatal jaundice and skin diseases and increasing awareness among the people towards the use of new technologies.
Among all regions, the Asia-Pacific region is anticipated to grow at a considerable CAGR over the forecast period due to the rising construction of hospitals and specialized clinics to offer effective healthcare solutions. Apart from this, the increasing healthcare expenditure among the masses is contributing to the growth of the market. In 2019, China's healthcare import and export volumes both saw an increase, reaching the highest levels since 2011. Europe, Asia, and North America were China's top three continental partners for healthcare foreign trade. Major factors and drivers that are shaping the sector in China, especially the increasingly supporting role of the Chinese government in issuing key development plans and regulations, as well as the rapidly aging Chinese population. China's pharmaceutical industry has been steadily expanding and is predicted to reach $161.8 billion by the end of 2023, accounting for around 30% of the worldwide market. However, because top Chinese pharmaceutical businesses and multinational MNC pharmaceutical companies (including those from the US) have dominated most market sales, chances for US SME pharmaceutical companies to explore are restricted.
The major companies serving the phototherapy equipment market include: Daavlin Company, Aeroflow, Inc., Philips Lighting Holding B.V., Signify Holding, Atom Medical Corporation, Herbert Waldmann GmbH & Co. KG, Hill-Rom Holdings, Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in April 2022, Philips signed a long-term strategic partnership with Oulu University Hospital Finland to deliver advanced image-guided specialist care. They will all be equipped with Philips' image-guided therapy system Azurion with FlexArm an advanced image-guided therapy platform that offers the latest innovations to help physicians improve efficiency, workflow, and treatment outcomes.